Evidence map›Paper›PMID 27805590›Full record

ArticleJournal of visualized experiments : JoVE2016

Assessing Retinal Microglial Phagocytic Function In Vivo Using a Flow Cytometry-based Assay.

Salome Murinello, Stacey K Moreno, Matthew S Macauley, Susumu Sakimoto, Peter D Westenskow, Martin Friedlander

Open access · bronzeAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Microglia in the developing retina.Neural development · 2019
    Review
  5. Soluble CX3CL1 gene therapy improves cone survival and function in mouse models of retinitis pigmentosa.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Salome MurinelloDepartment of Cell and Molecular Biology, The Scripps Research Institute; smuri@scripps.edu.
Stacey K MorenoDepartment of Cell and Molecular Biology, The Scripps Research Institute.
Matthew S MacauleyDepartment of Chemical Physiology, The Scripps Research Institute.
Susumu SakimotoDepartment of Cell and Molecular Biology, The Scripps Research Institute.
Peter D WestenskowDepartment of Cell and Molecular Biology, The Scripps Research Institute; The Lowy Medical Research Institute.
Martin FriedlanderDepartment of Cell and Molecular Biology, The Scripps Research Institute.
Scripps Research Institute · USThe Lowy Medical Research Institute · US

Funding

INTEGRINS AND OCULAR ANGIOGENESISR01EY011254 · NEI · SCRIPPS RESEARCH INSTITUTE, THE · PI FRIEDLANDER, MARTIN · 1996 to 2016
$11.5M
MicroRNAs for therapy of visual disordersR24EY022025 · NEI · SCRIPPS RESEARCH INSTITUTE, THE · PI FRIEDLANDER, MARTIN · 2012 to 2016
$10.2M
NEI NIH HHS R01 EY011254NEI NIH HHS R24 EY022025
6 · The paper itself

Abstract

Microglia are the tissue resident macrophages of the central nervous system (CNS) and they perform a variety of functions that support CNS homeostasis, including phagocytosis of damaged synapses or cells, debris, and/or invading pathogens. Impaired phagocytic function has been implicated in the pathogenesis of diseases such as Alzheimer's and age-related macular degeneration, where amyloid-β plaque and drusen accumulate, respectively. Despite its importance, microglial phagocytosis has been challenging to assess in vivo. Here, we describe a simple, yet robust, technique for precisely monitoring and quantifying the in vivo phagocytic potential of retinal microglia. Previous methods have relied on immunohistochemical staining and imaging techniques. Our method uses flow cytometry to measure microglial uptake of fluorescently labeled particles after intravitreal delivery to the eye in live rodents. This method replaces conventional practices that involve laborious tissue sectioning, immunostaining, and imaging, allowing for more precise quantification of microglia phagocytic function in just under six hours. This procedure can also be adapted to test how various compounds alter microglial phagocytosis in physiological settings. While this technique was developed in the eye, its use is not limited to vision research.

Indexed as

NeurogliaPhagocytesRetinaFlow CytometryHumansMicrogliaPhagocytosis

Identifiers

PMID27805590
PMCPMC5092212
OpenAlexW2531021882

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.